Patents by Inventor Claudine Elvire Marie Bruck

Claudine Elvire Marie Bruck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF TYROSINE KINASE INHIBITOR AND HER-2/NEU FOR CANCER THERAPY
    Publication number: 20100028414
    Abstract: A method of treating cancer is described comprising administration of a 4-quinazolineamine and a vaccine targeting the HER-2/neu molecule, as well as a pharmaceutical combination comprising 4-quinazolineamines and a vaccine targeting the HER-2/neu molecule.
    Type: Application
    Filed: December 8, 2005
    Publication date: February 4, 2010
    Inventors: Claudine Elvire Marie Bruck, Catherine Marie Ghislaine Gerard
  • CASB618 polynucleotides and polypeptides and their use
    Patent number: 7470782
    Abstract: CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: December 30, 2008
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Claudine Elvire Marie Bruck, Jean-Pol Cassart, Thierry Coche, Carlota Vinals Y De Bassols
  • CASB414:antigen overexpressed in several tumors
    Patent number: 6635255
    Abstract: CASB414 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB414 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colon cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: October 21, 2003
    Assignee: SmithKline Beecham Biologicals s.a.
    Inventors: Claudine Elvire Marie Bruck, Jean-Pol Cassart, Thierry Coche, Carlota Vinals Y De Bassols